NCT05903898 Improving Stroke Care in North-Norway Through Artificial Intelligence
| NCT ID | NCT05903898 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital of North Norway |
| Condition | Ischemic Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2023-06-01 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective observational multi-center intervention study. The study aims to evaluate whether an artificial intelligence (AI) support tool for radiological image processing (StrokeSens, Circle NVI) can accelerate decision making and increase detection rate in patients with an acute ischemic stroke caused by intracranial large vessel occlusion (LVO) or medium vessel occlusion (MeVO) in Northern Norway. Relevant outcomes will be compared between centres with and without available software during the study period.
Eligibility Criteria
Inclusion Criteria: * Patients with acute stroke symptoms admitted to a participating hospital within 24 hours of symptom onset Exclusion Criteria: * Patients not available for follow-up assessments (e.g. non-resident)
Contact & Investigator
Agnethe Eltoft
PRINCIPAL INVESTIGATOR
University Hospital of North Norway
Frequently Asked Questions
Who can join the NCT05903898 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05903898 currently recruiting?
Yes, NCT05903898 is actively recruiting participants. Contact the research team at agnethe.eltoft@unn.no for enrollment information.
Where is the NCT05903898 trial being conducted?
This trial is being conducted at Tromsø, Norway.
Who is sponsoring the NCT05903898 clinical trial?
NCT05903898 is sponsored by University Hospital of North Norway. The principal investigator is Agnethe Eltoft at University Hospital of North Norway. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.